Company Description
Alkermes, whose name is Arabic for "magic potion," is working some biotech alchemy. The firm uses its proprietary drug-delivery systems to make...
Key Alkermes Financials
| Company Type | Public - NASDAQ (GS): ALKS Main Headquarters |
|---|---|
| Fiscal Year-End | March |
| 2007 Sales (mil.) | $240.0 |
| 2007 Employees | 830 |
More Alkermes Financials (11 pages)
Latest Alkermes Jobs powered by Monster.com
- Research Associate- Life Sciences
- Medical Writer
- Senior Medical Director/ Medical Director
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Alkermes's competition across multiple industries
Top Alkermes Competitors
Sponsored Links
The Business Directory
Alkermes Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Richard F. Pops | Network | E-mail |
| President and CEO | David A. Broecker | Network | E-mail |
| SVP, CFO, and Treasurer | James M. (Jim) Frates | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Alkermes News
- Alkermes Inc(GAAP) (ALKS.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 05:34:00 EDT)
- Alkermes Inc(Alt EPS) (ALKS.AL) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 05:34:00 EDT)
-
Alkermes Inc (NASD:ALKS) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 01:19:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.